Official: Chelsea Agree £60m Fee With Real Madrid For Alvaro Morata, Medical Now Pending

Alan Duffy

19th, July 2017

After losing out on Romelu Lukaku, Chelsea look to have finally signed a top-class striker, with the Blues reportedly agreeing a deal with Real Madrid to sign Alvaro Morata for a reported £60m.

Morata still has to agree personal terms and pass a medical, but once all that’s out of the way, the Spanish international will become Chelsea’s fourth signing of the summer, after Willy Caballero, Antonio Rudiger and Tiemoue Bakayoko.

UPDATE: Chelsea have since officially confirmed that they’ve struck a deal with Real Madrid for Morata, with a medical and personal terms pending…

After rejoining from Juventus in the summer of last year, Morata scored 20 goals for Real Madrid and lifted the La Liga and Champions League titles.

However, the 24-year-old struggled to secure a regular starting berth at the Bernabeu, and was ultimately deemed surplus to requirements by coach Zinedine Zidane.

Morata had been widely expected to end up at Manchester United this summer, even rumoured to have dyed his hair red in preparation for an Old Trafford move.

However, the Red Devils then switched their attention to Chelsea target Lukaku, ultimately usurping the west Londoners.

Now, Morata does get his wish to play in the Premier League and could well take the place of Diego Costa in the Chelsea squad, with his fellow countryman expected to leave Stamford Bridge before the start of the new season.

Tall, mobile and intelligent, Morata has won 20 senior caps with Spain and will no doubt be hoping that this move to the Premier League champions will help his cause for place in Julen Lopetegui’s squad ahead of next summer’s World Cup.

It sure will be interesting to see how Lukaku and Morata match up in the coming season.

You have already read 4 premium articles for free today
Access immediately the premium content with Multipass

Or come back tomorrow

Posted in Chelsea, Real Madrid, Transfers & Rumours

Share this article: Email

Leave a Reply